Knight Therapeutics | GUD - 流动资产

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 841.74M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	流动资产	更改		日
Acasti Pharma	USD 17.3M		3.22M	2025-09
Akebia Therapeutics	USD 243.48M		9.47M	2026-03
Alaunos Therapeutics	USD 970K		1.02M	2026-03
Aurora Cannabis	CAD 445.84M		22M	2025-12
Avita Medical	AUD 35.49M		760K	2025-12
Canopy Growth	CAD 524.67M		78.85M	2025-12
Cronos Group	USD 927.88M		16.21M	2026-03
Dianthus Therapeutics	USD 1.12B		710.47M	2026-03
Ionis Pharmaceuticals	USD 2.94B		52M	2026-03
IQVIA Holdings	USD 6.22B		29M	2026-03
Knight Therapeutics	CAD 394.84M		5.86M	2025-12
Moderna	USD 5.77B		774M	2026-03
Omeros	USD 69.65M		26.53M	2025-06
Organigram Holdings	CAD 256.54M		28.35M	2025-12
Organon & Co	USD 4.93B		580M	2026-03
Revvity	USD 2.13B		111.43M	2026-03
Tectonic Therapeutic	USD 239.89M		17.47M	2026-03
Tilray	USD 729.32M		28.18M	2025-09
Viatris	USD 10.92B		1.13B	2026-03
Xeris Pharmaceuticals	USD 251.68M		11.37M	2026-03